Open AccessBevacizumab toxicity in heavily pretreated recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancers
Author(s) -
J. Martin,
Renata R. Urban,
John B. Liao,
Barbara A. Goff
Publication year - 2016
Publication title -
journal of gynecologic oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.358
H-Index - 37
eISSN - 2005-0399
pISSN - 2005-0380
DOI - 10.3802/jgo.2016.27.e47
Subject(s) - medicine , bevacizumab , fallopian tube , toxicity , ovarian cancer , oncology , fallopian tube cancer , chemotherapy , gynecology , cancer
The use of bevacizumab in heavily pretreated EOC, FTC, or PPC is worth consideration.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom